FDA Inspection 1191477 — South Texas Blood & Tissue Center
The FDA completed an inspection of South Texas Blood & Tissue Center on Nov 21, 2022 in Live Oak, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 21, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Live Oak, TX (United States)